STRO-004
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STRO-004, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]